MARKET

ORGO

ORGO

Organogenesis Hldgs Inc
NASDAQ
2.380
+0.090
+3.93%
After Hours: 2.360 -0.02 -0.84% 19:49 04/10 EDT
OPEN
2.290
PREV CLOSE
2.290
HIGH
2.435
LOW
2.270
VOLUME
2.54M
TURNOVER
--
52 WEEK HIGH
7.08
52 WEEK LOW
2.210
MARKET CAP
306.16M
P/E (TTM)
15.48
1D
5D
1M
3M
1Y
5Y
1D
Weekly Buzz: MGNX Resumes LINNET; GSK Wins China Nod; FDA Okays Waters; NBIX Snaps Up SLNO
NASDAQ · 2d ago
What's Going On With Organogenesis Stock On Wednesday?
Benzinga · 4d ago
Morning News Wrap-Up 4/7/26: Tuesday’s Biggest Stock Market Stories!
TipRanks · 5d ago
Organogenesis: Clinical Win De-Risks 2026, Recovery In Sight
Seeking Alpha · 5d ago
Midday Fly By: Health insurers get ‘positive surprise’ from CMS
TipRanks · 5d ago
BUZZ-U.S. STOCKS ON THE MOVE-Apple, Intel, Alignment Healthcare
Reuters · 5d ago
Video: Health insurers rise after CMS finalizes 2027 Medicare payment hike
TipRanks · 5d ago
Morning Movers: Broadcom gains following pact to supply custom TPUs for Google
TipRanks · 5d ago
More
About ORGO
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. It offers a portfolio of regenerative products to address patient needs across the continuum of care. Its wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for the treatment of DFUs; PuraPly AM as an antimicrobial barrier, cross-linked with extracellular matrix scaffold for a variety of wound types; and Affinity, Novachor and NuShield placental allografts to address a variety of wound sizes and types as a protective barrier and extracellular matrix scaffold. Its sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM and PuraPly SX for the management of open wounds in a surgical setting.

Webull offers Organogenesis Holdings Inc stock information, including NASDAQ: ORGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ORGO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ORGO stock methods without spending real money on the virtual paper trading platform.